Global Pleurisy Treatment Market Size, by Diagnosis Device (Thoracentesis, Video Assisted Thoracic Surgery), by Treatment (Antibiotics, Antifungals), by End User (Hospital) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1071382
  • |
  • Publishe Date : June 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Pleurisy Treatment Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increasing prevalence of infectious diseases is driving the market growth. However high cost of the treatment might restraint the market growth.

The global pleurisy treatment market is primarily segmented based on diagnosis device, treatment, end user and regions.

On the basis of diagnosis device, the market is split into:
* Thoracentesis
* Video Assisted Thoracic Surgery
* Imaging Devices (MRI, Ultrasound, Other Imaging Devices)
* Blood Test
* Other Diagnosis Devices

On the basis of treatment, the market is split into:
* Antibiotics
* Antifungals
* Blood Thinners
* Other Treatments

On the basis of end user, the market is split into:
* Hospital
* Clinic
* Other End Users

Moreover, the market is classified based on region and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Scanlan International
* Sontec Instruments
* Teleflex
* Integra lifesciences
* Olympus Corporation
* Delacroix-Chevalier
* Wexler Surgical
* Myra & Co.
* GE Healthcare
* Siemens Healthineers

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, diagnosis device, treatment, end user and market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions diagnosis device, treatment, end user and options with qualitative and quantitative information and facts

Target Audience:
* Pleurisy Treatment Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Pleurisy Treatment Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Pleurisy Treatment Market - Porter\'s Five Forces Analysis
4.4. Global Pleurisy Treatment Market - PESTEL Analysis

5. Global Pleurisy Treatment Market, by Diagnosis Device
5.1. Global Pleurisy Treatment Market, Size and Forecast, 2015-2026
5.2. Global Pleurisy Treatment Market by Thoracentesis, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Pleurisy Treatment Market by Video Assisted Thoracic Surgery, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Pleurisy Treatment Market by Imaging Devices, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.4.3. Global Pleurisy Treatment Market by MRI, 2015-2026
5.4.3.1. Market size and forecast, 2015-2026
5.4.4. Global Pleurisy Treatment Market by Ultrasound, 2015-2026
5.4.4.1. Market size and forecast, 2015-2026
5.4.5. Global Pleurisy Treatment Market by Other Imaging Devices, 2015-2026
5.4.5.1. Market size and forecast, 2015-2026
5.5. Global Pleurisy Treatment Market by Blood Test, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global Pleurisy Treatment Market by Other Diagnosis Devices, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global Pleurisy Treatment Market, by Treatment
6.1. Global Pleurisy Treatment Market, Size and Forecast, 2015-2026
6.2. Global Pleurisy Treatment Market by Antibiotics, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Pleurisy Treatment Market by Antifungals, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Pleurisy Treatment Market by Blood Thinners, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Pleurisy Treatment Market by Other Treatments, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026

7. Global Pleurisy Treatment Market, by End User
7.1. Global Pleurisy Treatment Market, Size and Forecast, 2015-2026
7.2. Global Pleurisy Treatment Market by Hospital, 2015-2026
7.2.1. Key driving factors, trends and opportunities
7.2.2. Market size and forecast, 2015-2026
7.3. Global Pleurisy Treatment Market by Clinic, 2015-2026
7.3.1. Key driving factors, trends and opportunities
7.3.2. Market size and forecast, 2015-2026
7.4. Global Pleurisy Treatment Market by Other End Users, 2015-2026
7.4.1. Key driving factors, trends and opportunities
7.4.2. Market size and forecast, 2015-2026

8. Global Pleurisy Treatment Market by Region
8.1. Pleurisy Treatment Market Regional Analysis, 2015-2026
8.2. Global Pleurisy Treatment Market Revenue (USD Million) by Region, 2015-2026
8.3. North America Pleurisy Treatment Market, 2015-2026
8.3.1. North America Pleurisy Treatment Market Size and Forecast, 2015-2026
8.3.2. North America Pleurisy Treatment Market by Country, 2015-2026
8.3.2.1. U.S. Pleurisy Treatment Market, 2015-2026
8.3.2.2. Canada Pleurisy Treatment Market, 2015-2026
8.4. Europe Pleurisy Treatment Market, 2015-2026
8.4.1. Europe Pleurisy Treatment Market Size and Forecast, 2015-2026
8.4.2. Europe Pleurisy Treatment Market by Country, 2015-2026
8.4.2.1. Germany Pleurisy Treatment Market, 2015-2026
8.4.2.2. France Pleurisy Treatment Market, 2015-2026
8.4.2.3. Italy Pleurisy Treatment Market, 2015-2026
8.4.2.4. UK Pleurisy Treatment Market, 2015-2026
8.4.2.5. Spain Pleurisy Treatment Market, 2015-2026
8.4.2.6. Rest of Europe Pleurisy Treatment Market, 2015-2026
8.5. Asia Pacific Pleurisy Treatment Market, 2015-2026
8.5.1. Asia Pacific Pleurisy Treatment Market Size and Forecast, 2015-2026
8.5.2. Asia Pacific Pleurisy Treatment Market by Country, 2015-2026
8.5.2.1. Japan Pleurisy Treatment Market, 2015-2026
8.5.2.2. China Pleurisy Treatment Market, 2015-2026
8.5.2.3. India Pleurisy Treatment Market, 2015-2026
8.5.2.4. Rest of Asia Pacific Pleurisy Treatment Market, 2015-2026
8.6. South America Pleurisy Treatment Market, 2015-2026
8.6.1. South America Pleurisy Treatment Market Size and Forecast, 2015-2026
8.6.2. South America Pleurisy Treatment Market by Country, 2015-2026
8.6.2.1. Mexico Pleurisy Treatment Market, 2015-2026
8.6.2.2. Brazil Pleurisy Treatment Market, 2015-2026
8.6.2.3. Rest of South America Pleurisy Treatment Market, 2015-2026
8.7. Middle East & Africa Pleurisy Treatment Market, 2015-2026
8.7.1. Middle East & Africa Pleurisy Treatment Market Size and Forecast, 2015-2026
8.7.2. Middle East & Africa Pleurisy Treatment Market by Country, 2015-2026
8.7.2.1. Saudi Arabia Pleurisy Treatment Market, 2015-2026
8.7.2.2. South Africa Pleurisy Treatment Market, 2015-2026
8.7.2.3. Rest of Middle East & Africa Pleurisy Treatment Market, 2015-2026

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis/Top Player Positioning, 2018

10. Company Profiles
10.1. Scanlan International
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Benchmarking
10.1.4. Key Developments
10.2. Sontec Instruments
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Benchmarking
10.2.4. Key Developments
10.3. Teleflex
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Benchmarking
10.3.4. Key Developments
10.4. Integra lifesciences
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Benchmarking
10.4.4. Key Developments
10.5. Olympus Corporation
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Benchmarking
10.5.4. Key Developments
10.6. Delacroix-Chevalier
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Benchmarking
10.6.4. Key Developments
10.7. Wexler Surgical
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Benchmarking
10.7.4. Key Developments
10.8. Myra & Co.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Benchmarking
10.8.4. Key Developments
10.9. GE Healthcare
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Benchmarking
10.9.4. Key Developments
10.10. Siemens Healthineers
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Product Benchmarking
10.10.4. Key Developments

11. Key Insights

Content are not available

Choose License Type